Laborate Pharmaceutical India Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Laborate Pharmaceutical India Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $2.4M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Laborate Pharmaceutical India Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $2.4M Trade | TransData Nexus

Laborate Pharmaceutical India Limited

Indian Pharmaceutical Exporter · Respiratory & OTC Specialist · $2.4M Total Trade · DGFT Verified

Laborate Pharmaceutical India Limited is an Indian pharmaceutical exporter with a total trade value of $2.4M across 4 products in 2 therapeutic categories. Based on 72 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Caffeine ($950.0K), Vati ($595.5K), Ephedrine ($450.0K).

Laborate Pharmaceutical India Limited — Export Portfolio & Destination Treemap

Laborate Pharmaceutical India Limited pharmaceutical export portfolio — 4 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Laborate Pharmaceutical India Limited? — Company Overview & Market Position

Laborate Pharmaceuticals India Limited, established in 1985, is a prominent Indian pharmaceutical manufacturer headquartered in Panipat, Haryana. The company is publicly listed with the Corporate Identification Number (CIN) U24239HR1990PLC030835. Laborate specializes in producing a diverse range of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, catering to both domestic and international markets.

As of March 2026, Laborate Pharmaceuticals India Limited has reported a total export value of $2.4 million USD, with 72 shipments across four products in two therapeutic categories. The company's product portfolio is concentrated, with the top five products accounting for 100% of its exports. Laborate's commitment to quality is evident in its adherence to stringent manufacturing standards and its recognition by global health authorities such as the World Health Organization (WHO).

What Does Laborate Pharmaceutical India Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Caffeine$950.0K 2

Product Portfolio — Top 4 by Export Value

Laborate Pharmaceutical India Limited exports 4 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Caffeine	Respiratory & OTC	$950.0K	19	0.9%	14
2	Vati	Ayurvedic & Herbal Products	$595.5K	35	2.3%	10
3	Ephedrine	Respiratory & OTC	$450.0K	9	2.0%	6
4	Pseudoephedrine	Respiratory & OTC	$450.0K	9	3.8%	4

Laborate Pharmaceutical India Limited exports 4 pharmaceutical products across 2 therapeutic categories with a total export value of $2.4M. The top category is Respiratory & OTC (75.6% of portfolio), followed by Ayurvedic & Herbal Products (24.4%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Laborate Pharmaceutical India Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Laborate Pharmaceuticals operates multiple manufacturing units across India, each equipped with state-of-the-art technology to ensure high-quality production. The primary facility, located in Panipat, Haryana, is WHO-GMP certified and specializes in small volume parenterals, ophthalmic preparations, tablets, capsules, and external preparations.

In 2004, the company expanded with a GMP-certified plant in Paonta Sahib, Himachal Pradesh, focusing on small volume parenterals, ophthalmic preparations, tablets, capsules, dry syrups, and external preparations. The largest facility, established in 2010 in Paonta Sahib, adheres to USFDA and European GMP standards, manufacturing oral solid dosage forms, injectables, ophthalmic preparations, external applications, oral liquids, and dry syrups.

In 2023, Laborate inaugurated two additional units: one in Salwan, Karnal, Haryana, dedicated to Ayurvedic and cosmetic products, and another in Satiwala, Paonta Sahib, Himachal Pradesh, equipped to produce general products, beta-lactam products, and cephalosporin products.

3Key Leadership

Laborate Pharmaceuticals India Limited is led by a team of experienced professionals committed to the company's growth and success.

Shri Ajay Bhatia serves as the Chairman and Whole-time Director. A first-generation entrepreneur, he holds a bachelor's degree in pharmacy and founded Laborate Pharmaceuticals in 1990.

Shri Sanjay Bhatia is the Managing Director and co-founder. After completing his graduation, he joined Laborate Pharmaceuticals and has been instrumental in its expansion and success.

Mr. Parag Bhatia, Director, represents the new generation of leadership at Laborate. With a Master's in International Management from Royal Holloway, University of London, he brings a global perspective to the company. Under his guidance, Laborate aims to expand its global footprint and diversify into new therapeutic categories.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Laborate Pharmaceutical India Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Laborate Pharmaceuticals has made significant strides in entering regulated markets, enhancing its global presence.

European Union (EU): In 2024, Laborate received EU-GMP certification, marking its formal entry into the European market. This certification underscores the company's commitment to adhering to stringent European manufacturing standards.

United States (US): Laborate has been actively pursuing approvals for its products in the US market. While specific details on FDA approvals are not publicly disclosed, the company's adherence to international quality standards positions it favorably for future market access.

United Kingdom (UK) and Australia: Laborate is in the process of obtaining necessary certifications and approvals to enter these markets, aiming to expand its reach in developed regions.

Japan: The company is exploring opportunities to enter the Japanese market, focusing on compliance with local regulatory requirements and quality standards.

Emerging Markets

Laborate Pharmaceutical India Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Laborate Pharmaceuticals has been actively working towards obtaining approvals from the U.S. Food and Drug Administration (FDA).

FDA Facility Registrations: The company has registered its manufacturing facilities with the FDA, ensuring compliance with U.S. manufacturing standards.

Approved ANDAs: Laborate is in the process of submitting Abbreviated New Drug Applications (ANDAs) for its products, aiming for approval to market generic drugs in the U.S.

DMF Filings: The company has filed Drug Master Files (DMFs) with the FDA, providing detailed information about the manufacturing process and quality control measures for its products.

Inspection History: Laborate's facilities have undergone FDA inspections, and the company has addressed any observations to maintain compliance with regulatory requirements.

2WHO & EU GMP

Laborate Pharmaceutical India Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Laborate Pharmaceuticals operates in a competitive environment, facing challenges from both domestic and international players.

Top Competitors: The company competes with other Indian pharmaceutical manufacturers and global companies offering similar product ranges.

Market Share Comparison: Laborate's market share varies across different therapeutic categories, with a focus on respiratory and over-the-counter (OTC) products.

Head-to-Head Analysis: The company's emphasis on quality, affordability, and regulatory compliance positions it favorably against competitors in the market.

2Key Differentiators

Laborate Pharmaceuticals distinguishes itself through several key factors.

Unique Strengths: The company's extensive product portfolio, commitment to quality, and adherence to international manufacturing standards set it apart in the industry.

Buyer Due Diligence Brief — Evaluating Laborate Pharmaceutical India Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Laborate Pharmaceuticals has established itself as a reliable supplier in the pharmaceutical industry.

Overall Track Record: The company has a history of delivering quality products and maintaining strong relationships with vendors, employees, business partners, and customers.

Export Volume and Consistency: Laborate's consistent export performance and adherence to international standards underscore its reliability as a supplier.

Reliability Indicators: The company's compliance with regulatory requirements and commitment to quality assurance reflect

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Frequently Asked Questions — Laborate Pharmaceutical India Limited

How many pharmaceutical products does Laborate Pharmaceutical India Limited export from India?

Laborate Pharmaceutical India Limited exports 4 pharmaceutical products across 2 therapeutic categories. The top exports are Caffeine ($950.0K), Vati ($595.5K), Ephedrine ($450.0K), Pseudoephedrine ($450.0K). Total export value is $2.4M.

What is Laborate Pharmaceutical India Limited's total pharmaceutical export value?

Laborate Pharmaceutical India Limited's total pharmaceutical export value is $2.4M, based on 72 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Laborate Pharmaceutical India Limited cover?

Laborate Pharmaceutical India Limited exports across 2 therapeutic categories. The largest are Respiratory & OTC (75.6%, 3 products), Ayurvedic & Herbal Products (24.4%, 1 products).

Get Full Laborate Pharmaceutical India Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.